Remove Compounding Remove Mayo Clinic Remove Specialty Pharmacies
article thumbnail

TikTok Videos on IBD Provide Low Quality Information

Drug Topics

Mayo Clinic. McDowell C, Farooq U, Haseeb M. Inflammatory Bowel Disease. Updated 2023 Aug 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: [link] 4. Inflammatory bowel disease (IBD). December 18, 2024. Accessed June 6, 2025. Crohn’s and Colitis Foundation. IBD Pharmacists.

FDA 247
article thumbnail

Pharmacists Take the Lead on Advanced Therapeutics

Pharmacy Times

Still, confusion remains over the role of pharmacy and therapeutics (P&T) committees in this process. Tichy, PharmD, MBA, vice chair of pharmacy formulary for Mayo Clinic, explained. This governance issue is a very hot topic,” Eric M.

50
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ASCO 2025: Promising Safety and Efficacy of Encorafenib and Binimetinib in Resected Stage II Melanoma

Pharmacy Times

Mayo Clinic. Akkooi A, Mandala M, Kicinski M, Primary analysis of the EORTC-2139-MG/Columbus-AD trial: A randomized trial of adjuvant encorafenib and binimetinib versus placebo in high-risk stage II melanoma with a BRAF-V600E/K mutation. J   Clin Oncol. 43, 2025 (suppl 17; abstr LBA9500). doi:10.1200/JCO.2025.43.17_suppl.LBA9500.

65
article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

Don (PMN): The specialty pharmacy. Dave (HR): Oh, no, I think the Specialty Pharmacy. Well the power of compound interest, you know, created a very different scenario. You better get people to a Virginia Mason or a Mayo Clinic or things like that. I mean Mayo Clinic, they found about 20% misdiagnosis.